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Abstract
Background: We characterized bacterial isolates from the na-
sopharynx of 84 Sickle cell disease patients 78 of whom were HbSS 
and 6 HbSC aged 4 four months to 15 years at Wesley Guild Hospital, 
Ilesa, southwestern Nigeria between February–September, 2014.
Method: Sterile cotton-tipped initially dipped into sterile saline the-
reafter was introduced into nasopharynx of each patient and the-
reafter applied onto sterile thioglycolate medium and incubated at 
370 C for 24 hr, When growth was noticed, samples were inoculated 
onto enriched, selective and differential bacteriologic media. Bacterial 
colonies that grew on such media were picked and characterized by 
Grams’ reaction, cultural, morphologic and biochemical methods. An-
tibiotic sensitivity tests were determined by the disc diffusion method. 
Demographic data relating to severity of SCD were provided.
Results: Altogether, 119 isolates were cultured from the na-
sopharynx. Gram positive bacteria predominated (65.54%) and Cory-
nebacterium spp (44.53%) dominated comprising of 19 (35.84%) 
Corynebacterium xerosis 11 (20.75%) Corynebacterium diphtheriae, 
10 (18.86) Corynebacterium pseudodiphtheriticum, 8 (15.09%) Cory-
nebacterium ulcerans, 3 (6.66%) Corynebacterium spp and 2 (3.77%) 
Corynebacterium jeikeium. Other Gram positive rods cultured were 
Arcanobacterium haemolyticum 6 (5%). Bacillus subtilis was 3 (2.5%), 
Actinomyces isrealli 3 (2.5%) and Norcadia asteroids 1 (0.84%). Low 
frequency of nasopharyngeal colonization recorded for Haemophilus 
influenzae 4.2%, S. pneumoniae 2.5% and S. aureus 4 (3.36%) and 
multiresistance was widespread for most isolates.
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Introduction
A recent report shows about one hundred and fif-
ty thousand infants are born annually with sickle 
cell disorder in Nigeria [1]. The country also ranks 
highest in the incidence of sickle cell trait in Africa 
[1]. According to a recent release by the Sickle Cell 
Foundation of Nigeria, one out of four Nigerians 
carries the sickle cell gene compared with the Uni-
ted States of America where one in twelve of Afri-
can Americans carry the sickle cell gene [1]. It has 
been shown nasopharyngeal bacterial colonization 
is common in the young infants which often prece-
des development of invasive diseases [2]. Knowled-
ge of nasopharyngeal bacteria colonization in chil-
dren is desirable because the nasopharynx harbors 
potential pathogens. Studies from the eastern and 
southern parts of Nigeria reported different types 
of bacterial agents cultured from the nasopharynx 
of children with sickle cell disease [3]. The types 
and number of nasopharyngeal bacteria recovered 
SCD patients depend on number of factors relating 
to the subject and administration of vaccines and 
antibiotics that suppress resident microflora but in-
crease emergence of resistant strains [4]. Some in-
vestigators have shown the use of vaccines mitigate 
the incidence of bacterial agents such as S. pneu-
moniae, Haemophilus influenzae type b and Neis-
seria meningitidis which influence the carrier rate 
of these bacteria often implicated in acute bacte-
rial meningitis [5]. For example in the United States, 
prior to the introduction of Haemophilus influenzae 
and pneumococcal vaccines, young children below 
the age of five years with SCD had a 13% risk of 
developing bacterial sepsis with mortality rate of 
30 and 10 % in patients with sepsis and meningi-
tis [6]. A recent study of the nasopharyngeal of S. 
pneumoniae carriage among rural Gambian in West 
Africa sub- region, showed the nasopharynx carria-
ge of Gambia infants by S. pneumoniae is rapid and 
highly dynamic, rising from prevalence of 1.5% at 
birth to 77% at 2 months, 5 months 86% and to 
78% at 12 months [7]. A Brazilian study reported 
the nasopharynx may constitute an ecological reser-
voir or source of dissemination of S. pneumoniae, 
H. influenzae, S. aureus and other Gram- negative 
bacilli (GNB) [2]. Infants and children are the most 
vulnerable to opportunistic infections mainly be-
cause of their relatively immature immune system 
besides the elderly and the immunocompromised. 
We have characterized the bacterial isolates from 
the nasopharynx of sickle cell disease children at-
tending the infant welfare clinic (IWC) at the Wesley 
Guild Hospital, Ilesa, southwestern Nigeria because 
the pattern of colonization, types and number of 
bacterial isolates from nasopharynx may differ from 
those reported from other regions. In addition, the 
study also evaluated the antibiotic resistant profile 
of the potential pathogenic bacterial isolates since 
this is an antibiotic pressurized community. We also 
evaluated the severity or otherwise of SCD in these 
patients in relation to frequency of blood transfu-
sion and hospitalization. We believe the results ob-
tained from our study will assist clinicians to better 
manage bacterial infections in children with SCD.
Conclusion: Indigenous microflora Corynebacterium spp predomi-
nated and low rate of nasopharyngeal colonization with H. influen-
zae, and S. pneumoniae recorded attributable to prophylactic use of 
penicillin and vaccines administration probably suppressed growth 
of organisms and inevitably increased resistance to many antibiotics. 
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Methods
Study Center
Ilesa where the study took place is a semi-urban 
town with a population of 277,904 inhabitants in 
Osun State in southwestern Nigeria and the Wesley 
Guild Hospital is one of the outpost hospitals emplo-
yed by the Obafemi Awolowo University Hospitals 
Complex (OAUTHC) to train medical students and 
other allied healthcare professionals. The hospital is 
located about 20 minutes’ drive from Ile-Ile where 
Obafemi Awolowo University, the parent institution 
is situated. 
Criteria inclusion
All participants were sickle cell disease patients 
that attended the infant welfare clinics of the 
hospital either because they were sick or had a 
routine checkup appointment with the attending 
physician. Each participant was recruited after we 
adequately explained the purpose of the study 
using each participant’s native dialect. Further-
more, demographic information relating to the 
each participant was obtained from interviews, 
questionnaire responses from guardian/ parent 
and case files managed by the attending physi-
cians. Ethical clearance for approval to undertake 
the study was given by the Ethics committee of 
the hospital. The age of the participants ranged 
from 4 months to 15 years comprising of 45 males 
and 39 females.
Collection of samples
Each sample was collected from each subject’s 
pharynx by the attending physician using a steri-
le cotton- tipped applicator that was initially dip-
ped into sterile normal saline and introduced into 
sterile thioglycolate broth. All such samples were 
incubated at 37oC for 24 hours for growth and 
further studied. Duplicate samples were prepared 
for anaerobes and incubated in AnaeroPack Jar 2.5 
Liter, Order No.50-25, product of Mitsubishi Gas 
Chemical Company Co., Inc. Japan. All samples 
were analyzed within 24 hours of collection.
Methods of isolation
The bacterial isolates were identified by Gram 
stain and growth characteristics on mannitol salt 
agar (Oxoid, Basingstoke, UK), blood agar, eosin-
methylene blue agar, triple sugar iron agar, sulfi-
de indole motility medium, citrate agar (Oxoid) 
and Analytical Profile index (API) rapid biochemical 
test. API kits used include API20E and API Staph 
(Biomerieux, France). Coagulase and catalase tests 
and sensitivity to Taxo A (0.04 units of bacitracin) 
and Taxo P (5 µg) ethylhydrocupreine hydrochloride 
(optochin; BD Diagnostics, Difco Laboratories, De-
triot, USA) were also employed for identification. 
All bacterial isolates were tested for their sensitivity 
to commonly prescribed antibiotics using the Kirby-
Bauer method. The antibiotics used were obtained 
from Abtek Biologicals Limited (Liverpool, UK) and 
included erythromycin (15 µg), gentamicin (10 µg), 
agumentin (30 µg), streptomycin (10 µg), tetracycli-
ne (10 µg), chloramphenicol (10 µg), nalidixic acid 
(30 µg), ampicillin (10 µg), nitrofurantoin (200 µg), 
ciprofloxacin (5 µg), ceftriaxone (30 µg), oxacillin (1 
µg), kanamycin (30 µg ), and. S. aureus ATCC 25923 
and Enterobacter aerogenes (American Type Cultu-
re Collection, Rockville, USA) were used as control 
organisms.
Statistical analysis
The resulting data was analysed by the descriptive 
analysis and t-test using SPSS version 16.0 software. 
Significant difference was taken as p < 0.05.
Results
Data relating to patients’ were obtained from their 
records and personal files and analyzed. Table 1 
shows the profile of the genotype, the frequen-
cy of blood transfusion and hospitalization of the 
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SCD patients. Out of the 84 SCD patients scree-
ned, 78 (92.85%) were HbSS of which 41 (52.5%) 
male and 37 (47.4%) female compared to 6 with 
HbSC of which 4 (66.7%) was male and 2 (33.3%) 
female. The number of blood transfusion in the 12 
months prior the study was analyzed. Of the 81 
patients whose records were available, 1 patient 
received blood transfusion 4 times; another patient 
had 3 blood transfusions within the period. 5 pa-
tients also received blood transfusion twice while 
23 patients had only one transfusion within the pe-
riod. In contrast, 51 patients did not receive blood 
transfusion. Regarding hospitalization in this same 
group was also based on the number of admis-
sion in 12 months prior to study. One patient was 
hospitalized 5 times, two 4 times, 5 patients were 
hospitalized 3 times. Furthermore, eight patients 
were hospitalized 2 times while 33 patients in the 
group were hospitalized only once. In contrast, 32 
patients among the group were not hospitalized 
(Table 1).
Similarly, the number of significant pain episodes 
in 12 months preceding the study period was asses-
sed. SCD severity was calculated from the number 
of hospitalization, blood transfusion and significant 
pain (significant pain referred to pains necessitating 
hospital visits (either as outpatient or inpatient and 
requiring analgesics) (Fig 1).






No of times subject 
received blood 
transfusion
No of times subject was 
hospitalized
Subjects’ Genotype
4 3 2 1 0 5 4 3 2 1 0 SC (M) SC (F) SS (M) SS (F)
1 -11 2 - - - 1 1 - - - - 1 1 1 0 1 0
12-60 29 - 1 2 8 17 - 2 3 3 11 10 2 0 15 12
61-120 35 1 - 1 9 22 1 - 2 4 15 11 0 0 17 18
121-180 18 - - 2 5 11 - - - 1 6 10 1 2 8 7
Total 84* 1 1 5 23 51 1 2 5 8 33 32 4 (66.67) 2 (33.33) 41 (52.5) 37 (47.4)
*= information on blood transfusion and number of hospitalization for three subjects was unavailable
Figure 1:  Severity of sickle cell disease among patients.
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Socioeconomic class (SEC) of parents was deri-
ved using the occupations and highest educatio-
nal qualifications of both parents. 24 (30%) each 
of the SCD patients’ parents were categorized in 
the upper and middle socioeconomic classes whi-
le 32 (40%) were classified in the low socioeco-
nomic class.
Table 2 reflects the distribution of bacterial isola-
tes from the nasopharynx of the 84 SCD patients. 
A total of 119 bacterial isolates were cultured from 
84 patients averaging 1.42 bacteria/ sample. Of 
the 119 isolated cultured from the nasopharynx of 
the SCD patients, 44.53% were Corynebacterium 
spp comprising of 19 (35.84%) Corynebacterium 
xerosis 11 (20.75%) Corynebacterium diphtheriae, 
10 (18.86) Corynebacterium pseudodiphtheriticum, 
8 (15.09%) Corynebacterium ulcerans, 3 (6.66%) 
Corynebacterium spp and 2 (3.77%) Corynebac-
terium jeikeium. Other Gram positive rods cultu-
red were Arcanobacterium haemolyticum 6 (5%) 
of the total 119 cultured, Bacillus subtilis was 3 
(2.5%), Actinomyces isrealli 3 (2.5%) and Norcadia 
asteroids 1 (0.84%). Amongst the Gram positive 
cocci (Staphylococci) constituted 7.5% of the total 
bacterial isolates with CONS being 55.5% of the 
Staphylococci and S. aureus 45.5%. Streptococ-
ci constitute (2.5%) of the total bacterial isolates 
seen, all of which were S. pneumoniae isolates. 
The lactose fermenters constitute 9.24% of the 
total bacteria consisting of Klebsiella pneumoniae 
3 (27.27%), E. coli, Enterobacter aerogenes and 
Citrobacter freundii 2 (18.18%) each and Citrobac-
ter diversus and Klebsiella oxytoca 1 (9.09%) each. 
The non- lactose fermenters were 30 (25.21%) of 
the total bacterial isolates of which, 7 (23.33) were 
Pseudomonas aeruginosa, Streptobacillus monili-
formis 6 (20%) each, 5 (16.66%) each of Heamo-
philus influenzae and Sarcina spp, Salmonella ente-
ritidis 3 (10%) and Shigella dysenteriae, Moraxella 
catarrhalis 2 (6.66%) each.
The antibiotic resistant pattern of the four patho-
gens is presented in Table 3. Similarly Table 4 repre-
Table 2.  Distribution of bacterial isolates cultured 
























Corynebacterium spp 3 2.5
Bacillus subtilis 3 2.5
Actinomyces isrealli 3 2.5
Corynebacterium jeikeium 2 1.7
Norcadia asteroides 1 0.84
Gram Positive Cocci
CONS (coagulase negative 
Staphylococci)
5 4.2







Klebsiella pneumoniae 3 2.5
Escherichia. coli 2 1.7
Enterobacter aerogenes 2 1.7
Citrobacter freundii 2 1.7
Citrobacter diversus 1 0.84








Heamophilus influenzae 5 4.2
Sarcina spp 5 4.2
Salmonella enteritidis 3 2.5
Shigella dysenteriae 2 1.7
Moraxella catarrhalis 2 1.7
Total 119 (99.92%)
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AUG AMP OXA CRO ERY TET STR GEN KAN CHL NAL CIP NIT
Haemophilus 
influenzae
5 5 3 (60) 4 (80) 4 (80) 4 (80) 3 (60) 5 (100) 2 (40) 0 0 5 (100) 5 (100) 3 (60) 3 (60)
Staphylococcus 
aureus
4 4 1 (25) 4 (100) 0 0 4 (100) 1 (25) 0 1 (25) 0 0 4 (100) 0 0
Streptococcus 
pneumoniae
3 3 3 (100) 3 (100) 3 (100) 3 (100) 0 1 (33.33) 2 (66.67) 0 0 3 (100) 3 (100) 0 0
Moraxella 
catarrhalis
2 2 1 (50) 2 (100) 2 (100) 2 (100) 1 (50) 0 0 0 0 2 (100) 2 (100) 0 0
Keys to abbreviations:  TET = Tetracycline STREP = Streptomycin; AMP = Ampicillin; GEN = Gentamycin; AUG = Augmentin; CRO = Ceftriaxone; OXA = Oxacillin;  
CHL = Chloramphenicol; ERY = Erythromycin; KAN = Kanamycin; NIT = Nitrofurantoin; CIP = Ciprofloxacin; NAL = Nalidixic acid;  
Value in parenthesis=Number in % 
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Table 4.  Multiple Antibiotic Resistance Index of the predominant pathogenic bacterial isolates cultured 




Total no. of 
isolates tested
Total no. (%) 
resistant
Total no. (%) 
susceptible
MAR index
β-lactams Ampicillin 14 13 1 0.92
Augmentin 14 8 6 0.57
Oxacillin 14 9 5 0.64
Cephalosporins Ceftriaxone 14 9 5 0.64
Tetracyclines Tetracycline 14 7 7 0.50
Macrolides Erythromycin 14 8 6 0.57
Aminoglycosides Streptomycin 14 4 10 0.28
Gentamycin 14 1 13 0.07
Kanamycin 14 0 14 0
Chloramphenicol Chloramphenicol 14 10 4 0.71
Quinolones Nalidixic acid 14 14 0 1.0
Fluoroquinolones Ciprofloxacin 14 3 11 0.21
Nitrofurans Nitrofurantoin 14 3 11 0.21
sents the multiple antibiotic resistances of the four 
pathogens using MAR index.
Discussion and conclusion
The sickle gene confers an increased susceptibility 
to infection, especially to certain bacterial patho-
gens, and at the same time infection provokes a 
cascade of SCD-specific pathophysiological chan-
ges. Africa bears the highest burden of sickle cell 
disease on the globe. Our study characterized the 
nasopharyngeal bacterial isolates cultured from 84 
Sickle cell disease patients at the infant welfare 
clinic of the Wesley Guild Hospital, of which 78 
(92.85%) were HbSS of this 41 (52.56%) were ma-
les and 37 (47.44%) females. In addition, 6 (7.14%) 
were HbSC; 4 (66.66%) males and 2 (33.33%) fe-
males. Despite the fact that over 700 structural 
haemoglobin (Hb) variants have been identified 
worldwide, only (Hb S, Hb C) constitutes high 
frequencies in Africa [8]. Altogether, 119 isolates 
were cultured from the nasopharynx of the SCD 
patients, consisting of 78 (65.54%) Gram positi-
ve bacteria comprising 66 (55.46%) Gram positive 
rods and 12 (10.08%) Gram positive cocci domi-
nated and Gram negative isolates was (34.45%) 
of total bacterial recovered from SCD patients. 
The predominant Gram positive organism was 
Corynebacterium spp comprising 44.53% of the 
Gram positive rods of which Corynebacterium xe-
rosis predominated. The Gram positive cocci were 
5 (4.20%) CONS and S. aureus 4 (3.36%) and 3 
(2.52%) S. pneumoniae underscoring a low rate of 
nasopharyngeal colonization with these organisms 
in this center which may be attributable with the 
prophylactic use of penicillin in this center. Despite 
the high nasopharyngeal carriage which often is 
a determinant for invasive pneumococci in some 
regions [9], it is puzzling to note high carriage rates 
with low rates of invasive pneumococcal disease 
in sub-Saharan Africa [10, 11]. According to Kizito 
et al., [11] a significantly low rate of pneumococ-
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cal bacteremia in Ugandan children with sickle cell 
disease (6%, 3/47) [12], and other studies have in-
dicated low pneumococcal bacteremia in Nigerian 
children [13, 14]. However, in Zambia low rate of 
pneumococci frequency was attributable to strict 
antibiotic policy of the government that reduced 
access to sale of over the counter drugs. Our data 
showed widespread multiple antibiotic resistance 
among the four pathogens we tested. Our study 
shows all the 5 H. influenzae isolates tested were 
resistant to tetracycline, chloramphenicol and na-
lidixic acid. 4 isolates were resistant to ampicillin, 
oxacillin and third generation cephalosporin-cef-
triaxone while 3 isolates were resistant to augu-
mentin, erythromycin, ciprofloxacin and nitrofu-
rantoin. In addition, two of H. influenzae isolates 
were also resistant to streptomycin but none was 
resistant to gentamycin and kanamycin. Similarly, 
of the four S. aureus isolates cultured, all were 
resistant to ampicillin, erythromycin and nalidixic 
acid and 1 isolate was resistant to augumentin, 
tetracycline and gentamycin but none was resis-
tant to oxacillin, ceftriaxone, streptomycin, kana-
mycin, chloramphenicol, ciprofloxacin and nitro-
furantoin. Furthermore, our results reveal among 
the three S. pneumoniae isolates cultured from the 
nasopharynx, all were resistant to the beta lac-
tams antibiotics, augumentin, ampicillin, oxacillin 
and ceftriaxone. Two of the S. pneumoniae isola-
tes were resistant to streptomycin and one isolate 
to tetracycline, chloramphenicol and nalidixic acid. 
In contrast, none of the isolates was resistant to 
erythromycin, gentamycin, kanamycin, ciprofloxa-
cin and nitrofurantoin. Finally, among the Moraxe-
lla catarrhalis isolates tested, all were resistant to 
ampicillin, oxacillin, ceftriaxone, chloramphenicol, 
nalidixic acid. However, 1 isolate was resistant to 
augumentin, erythromycin but all were sensitive 
to the other antibiotic used (Table 3). Because of 
susceptibility to severe pneumococcal infection, 
children with sickle cell disease (SCD) routinely re-
ceive penicillin prophylaxis which unintentionally 
increased the rates of penicillin resistance repor-
ted throughout the world, this practice has led to 
emergence of penicillin resistant S. pneumoniae 
(PRSA) untamable to treatment with β-lactams in 
particular and also a variety of different antibiotics. 
The predominance of Corynebacterium spp seen 
in our study among these SCD patients may also 
be related to indigenous microflora which repre-
sents commensals of the nasopharynx that limit 
the growth of pathogenic organisms by phenome-
non of microbial antagonism. Furthermore, Gram 
negative organisms accounted for 34.46% of the 
nasopharyngeal isolates comprising of 11 (26.82%) 
lactose fermenters and 30 (73.17%) non lactose 
fermenters. Colonization with Gram negative orga-
nisms specifically with lactose fermenters- E. coli, 
Klebsiella, Citrobacter and Enterobacter spp is of 
concern but may be attributable to patients’ perso-
nal hygiene. It is interesting to note that 40% of the 
population studied comes from low socioeconomic 
group (15) who live in overcrowded living conditions 
and lack portable drinking water are therefore at 
higher risk of parasitic infections such as malaria and 
diarrhoea. The low rate of nasopharyngeal coloni-
zation in children at this center with Haemophilus 
influenzae 5 (4.2%) and S. pneumoniae, may be 
attributed to administration of vaccines early in life 
in this environment. 
 The multiple antibiotic resistance (MAR) seen 
in our study was widespread among the four pre-
dominant pathogens. The MAR indices for the be-
ta-lactams for example, comprising of ampicillin, 
augumentin, oxacillin and ceftriaxone were 0.92, 
0.57, 0.64 and 0.64 respectively. For tetracycline, 
the MAR value was 0.50; and for erythromycin 
0.57. Regarding aminoglycosides comprising of 
streptomycin, gentamycin and kanamycin their 
MAR indices were 0.28, 0.07 and 0.00 respec-
tively. For chloramphenicol the MAR index was 
0.71, while for nalidixic acid it was 1.00. When 
we analyzed ciprofloxacin and nitrofurantoin, MAR 
value was 0.21 for each antibiotic. These results 
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suggest widespread multiple antibiotic resistance 
among organisms cultured from SCD patients. Our 
study showed an unexpected high frequency of 
nasopharyngeal colonization rarely seen with in-
digenous microflora specifically Corynebacterium 
spp at this center. This finding suggests routine use 
of prophylactic penicillin may have suppressed S. 
pneumoniae nasopharyngeal colonization among 
the subjects. It also suggests routine vaccination of 
infants and children in the center may be assisting 
in reducing the frequency of colonization by S. 
pneumoniae and Haemophilus influenzae among 
subjects. Our data show beta- lactam antibiotics 
are virtually ineffective against the organisms cul-
tured from these SCD patients compared with 
aminoglycosides, quinolones and nitrofurantoin. 
This observation is of epidemiological significance 
in the event of an epidemic in this center. The 
widespread resistance recorded for the majority 
of nasopharyngeal isolates recorded in our study 
requires urgent and necessity of instituting effec-
tive antibiotic policy in this center to reduce the 
frequency of drug- resistant in this population.
Studies have shown SCD not only originates 
from abnormality of RBC but also is a multisys-
tem disorder, affecting virtually every organ of 
the human body. These conditions include hae-
molysis, many haemotological complications, va-
soocclusion, infection and organ dysfunction (8). 
Our study reveals 49 (60.49%) of the SCD patients 
were hospitalized at least once. Thirty (61.22%) of 
these patients also received blood transfusion at 
least once. SCD patient suffers chronic haemolytic 
anaemia which allows the patient to carry on nor-
mal activities at steady state hemoglobin with na-
rrow reserve capacity to accommodate strenuous 
physical activities [16, 17, 18, 19]. The role of the 
blood transfusion in the SCD patient is meant at in-
creasing the level of hemoglobin, improve oxygen 
delivery and reduce proportion of sickle RBCs in 
circulation [8]. In addition, infection caused by H. 
influenzae and S. pneumoniae is a major cause of 
concern for children with SCD with haemoglobulin 
SS; HbSS and HbSC as these children are at risk of 
bacteremia and chronic anemia that lead to early 
loss of splenic function [6]. Our results, however 
suggest despite their genotypes, these children 
had low rate of colonization with H. influenzae 
and S. pneumoniae at this center which is interes-
ting and may lead to further reduction in infection 
with these organisms. Furthermore, the preponde-
rance of indigenous microflora in nasopharynx of 
these children by organisms such as Corynebacte-
rium spp most of which are commensals, are in 
competition with pathogens because of microbial 
antagonism, an aspect of innate immunity will re-
duce the colonization with pathogens. Besides, ad-
ministration of both pneumococci and influenzae 
vaccines in booster doses may also lower the rate 
of nasopharyngeal colonization [20]. In conclusion, 
Gram positive bacterial isolates predominated in 
this study (65.45%) compared to (34.55%) of Gram 
negative bacteria. However Corynebacterium spp 
predominated. Low rate of nasopharyngeal colo-
nization with Haemophilus influenzae, Streptococ-
cus pneumoniae and Staphylococcus aureus strains 
was recorded. The study also recorded widespread 
multiple drug resistance among most isolates colo-
nizing the nasopharynx of SCD in this center which 
is worrisome suggesting for urgent institution of 
effective antibiotic policy to stem the tide of multi- 
drug resistant organisms in this center.
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